Whole-exome sequencing (WES) of samples from patients (pts) classified as exceptional responders (ER) vs poor responders (PO) to targeted therapies in pancreatic neuroendocrine tumours (pNETs).
Barriuso, Jorge Lamarca, Angela Manoharan, Prakash Moghadam, Sharzad Rogan, Jane Hayes, A Mansoor, Was
Barriuso, Jorge
Lamarca, Angela
Manoharan, Prakash
Moghadam, Sharzad
Rogan, Jane
Hayes, A
Mansoor, Was
Citations
Altmetric:
Abstract
Description
Date
2017
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Whole-exome sequencing (WES) of samples from patients (pts) classified as exceptional responders (ER) vs poor responders (PO) to targeted therapies in pancreatic neuroendocrine tumours (pNETs). 2017, 105: 19-19 Neuroendocrinology